We are transforming the healthcare capital markets.
Over the past 20 years, the effects of regulation and financial reform have transformed the nature of growth investing and significantly constrained access to capital for the fastest growing, most valuable companies in the world.
In the face of these challenges, Healthios' platform is dedicated to making the global emerging growth capital markets more dynamic, accessible and efficient. Our proprietary platform is based on 3 governing principles:
- To expand the size of the global emerging growth capital markets by eradicating the costs of growth capital investing.
- To reduce the risk of growth investing by deploying technology to transform the origination, execution and portfolio management processes throughout the investment horizon.
- To maximize liquidity, valuation -- and investment returns -- by re-establishing the IPO as the cornerstone of the emerging growth financial markets.
Since 2014, Healthios clients have raised more than $1 billion of investment capital. In 2016, we are launching CapBridge: the first fully-integrated pre-IPO and IPO capital market dedicated exclusively to emerging growth companies.